Following an inter partes review requested by 10x Genomics, the Patent Trial and Appeal Board invalidated a number of claims in a RainDance patent.
The deal is expected to help Takara Bio Group expand its presence in next-generation sequencing library preparation and other markets.
The technology could eventually have applications in pathology as well as field-based diagnostic testing for infectious diseases.
The firm reported preliminary declining revenues for both the fourth quarter and full-year 2016 reporting periods.
The method allows analysis of copy number at the individual cell level with greater coverage uniformity and more reliable detection than other approaches.
The kit uses a proprietary non-enzymatic method to prepare intact, single-cell suspensions from tissue in less than 10 minutes.
The platform uses a fluidics-based method to lyse blood cells and concentrate pathogens from patient samples.
The partners will use Namocell's Single Cell Dispenser platform for cell sorting and to capture CTCs.
The deal is expected to broaden Takara's portfolio of products for next-generation sequencing library preparation and genetic analysis.
The new assays — one targeting 17 genes and one targeting 77 genes — are based on the CAPP-Seq technology developed by Stanford University
The companies will combine their respective technologies to provide an integrated analytical and next-generation sequencing sample preparation offering for cancer research.
The researchers developed a sample prep technique similar to those used to study ancient DNA to amplify and sequence HIV genomes from archival patient samples.
During a live webcast, CTO Clive Brown provided an update on the company's development plans and upcoming updates.
The partners plan to improve yields from small input samples and provide better sequencing libraries.
Pisces will market and sell WaveSense's products, including its EpiSep platform and bead-based CD138+ cell isolation technology, in Ireland and the UK.
The funding supports development of biochemistry and microfluidics for digital droplet multiple displacement amplification.
The approval also covers the company's magnetic bead technology for isolation of CD138-positive cells, which it plans to commercialize in Europe.
DNA Genotek's Omnigene Gut kit worked just as well as freezing for stabilizing fecal microbiome samples, but at room temperature, according to a new study.
The revenue increase was driven by strong growth in instrument and consumable sales, which more than offset declining grant revenue.
The firm sold four ICell8 Single-Cell Systems, but noted the sales cycle is longer than anticipated and it is thus lowering full-year revenue guidance.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.